Roche Investor
Roche is a pharmaceutical and diagnostics company that has been committed to improving lives since its founding in 1896. They create innovative medicines and diagnostic tests that help millions of patients globally. Roche specializes in oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. Their products include cancer treatments like Avastin, Herceptin, and MabThera, which are also effective in treating rheumatoid arthritis, anemia, and osteoporosis. Roche also provides research and development, production, and automated instruments, software, and IT solutions for in-vitro diagnostics and research.
Connections from
Headquarters:
Basel, Basel-City, Switzerland
Investor Type:
Pharma Company
Founded Date:
Jan 15, 1896